The global mammalian cell fermentation technology market size is expected to reach USD 76.24 billion by 2030. A crucial step in the creation and manufacture of biologics is the utilization of mammalian cell fermentation technology. Several biologics are made with this fermentation technology which is used to treat a variety of illnesses including cancer, autoimmune disorders, and infectious diseases. Mammalian cells, primarily Chinese Hamster Ovary (CHO) cells, are employed in the technique to make proteins that are then purified and combined to create biologic pharmaceuticals. These cells are cultured in large-scale bioreactors. The need for biologics and biosimilars has increased the significance of technology in the biopharmaceutical sector. ![Global Mammalian Cell Fermentation Technology Market]( "Global Mammalian Cell Fermentation Technology Market")
The mammalian cell fermentation technology industry is expected to see significant growth in the coming years due to various factors, including the increasing demand for biologics and biosimilars, advancements in mammalian cell culture techniques, and the growing prevalence of chronic diseases. For instance, in January 2021, Merck KGaA acquired AmpTec, a German-based biotech company. This acquisition will enable Merck to expand its capabilities in mRNA technology, a field that is rapidly growing in importance for the development of biologics, biosimilar and mammalian cells. Additionally, the acquisition will strengthen Merck's position in the fast-growing mRNA contract development and manufacturing organization (CDMO) market.
The COVID-19 pandemic has also emphasized the value of biology and the necessity for efficient medicines, which has aided in the expansion of the marketplace for mammalian cell fermentation technology industry. For instance, the COVID-19 vaccine was created by the biotech company Moderna using mammalian cell fermentation technology, and it has been approved for use in emergencies worldwide. This example highlights how mammalian cell fermentation technology has played a critical role in the development of life-saving treatments and therapies during the pandemic and its potential for future growth.
The mammalian cell fermentation technology industry is expected to see significant growth in the coming years due to various factors, including the increasing demand for biologics and biosimilars, advancements in mammalian cell culture techniques, and the growing prevalence of chronic diseases. For instance, in January 2021, Merck KGaA acquired AmpTec, a German-based biotech company. This acquisition will enable Merck to expand its capabilities in mRNA technology, a field that is rapidly growing in importance for the development of biologics, biosimilar and mammalian cells. Additionally, the acquisition will strengthen Merck's position in the fast-growing mRNA contract development and manufacturing organization (CDMO) market.
The COVID-19 pandemic has also emphasized the value of biology and the necessity for efficient medicines, which has aided in the expansion of the marketplace for mammalian cell fermentation technology industry. For instance, the COVID-19 vaccine was created by the biotech company Moderna using mammalian cell fermentation technology, and it has been approved for use in emergencies worldwide. This example highlights how mammalian cell fermentation technology has played a critical role in the development of life-saving treatments and therapies during the pandemic and its potential for future growth.
Mammalian Cell Fermentation Technology Market Report Highlights
- By type, Chinese Hamster Ovary (CHO) cell fermentation segment dominated the market in 2022 with a share of 65.52%, due to its well-understood genetic and biochemical characteristics, high productivity, affordability, and regulatory acceptability, which have been optimized and researched over time
- By application, monoclonal antibodies had a dominant presence in the market with a share of 42.38% in the year 2022, due to their effectiveness in treating various diseases, including COVID-19
- By end-use, CMOs & CDMOs segment held the largest market share of 51.00% in 2022, due to the increasing trend of outsourcing biopharmaceutical production to third-party manufacturers. CDMOs offer specialized expertise, infrastructure, and equipment necessary for efficient production, which makes them a popular choice among biopharmaceutical companies
- North America established a strong regional position in the market with a 37.61% share in 2022. Due to its highly developed healthcare infrastructure, favorable government policies, and a strong presence of major biopharmaceutical companies
Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Demand for Biologics
3.4.2. Increasing Investment in Research and Development of Novel Recombinant Proteins
3.4.3. Increasing Focus on Personalized Medicine and Precision Medicine
3.5. Market Restraint Analysis
3.5.1. High Cost Associated with The Production of Biologics Using Mammalian Cell Fermentation Technology
3.5.2. Regulatory Challenges
3.6. Penetration And Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Demand for Biologics
3.4.2. Increasing Investment in Research and Development of Novel Recombinant Proteins
3.4.3. Increasing Focus on Personalized Medicine and Precision Medicine
3.5. Market Restraint Analysis
3.5.1. High Cost Associated with The Production of Biologics Using Mammalian Cell Fermentation Technology
3.5.2. Regulatory Challenges
3.6. Penetration And Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Mammalian Cell Fermentation Technology Market: Type Movement Analysis
4.2. Chinese Hamster Ovary (CHO) Cell Fermentation
4.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.3. Human Embryonic Kidney (HEK) Cell Fermentation
4.3.1. Human Embryonic Kidney (HEK) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.4. Baby Hamster Kidney (BHK) Cell Fermentation
4.4.1. Baby Hamster Kidney (BHK) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.5. Murine Myeloma Cell Fermentation
4.5.1. Murine Myeloma Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.6. Others
4.6.1. Other Types Market, 2018 - 2030 (USD Billion)
4.2. Chinese Hamster Ovary (CHO) Cell Fermentation
4.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.3. Human Embryonic Kidney (HEK) Cell Fermentation
4.3.1. Human Embryonic Kidney (HEK) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.4. Baby Hamster Kidney (BHK) Cell Fermentation
4.4.1. Baby Hamster Kidney (BHK) Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.5. Murine Myeloma Cell Fermentation
4.5.1. Murine Myeloma Cell Fermentation Market, 2018 - 2030 (USD Billion)
4.6. Others
4.6.1. Other Types Market, 2018 - 2030 (USD Billion)
Chapter 5. Application Business Analysis
5.1. Monoclonal Antibodies
5.1.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
5.2. Recombinant Proteins
5.2.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
5.3. Vaccines
5.3.1. Vaccines Market, 2018 - 2030 (USD Billion)
5.4. Hormones
5.4.1. Hormones Market, 2018 - 2030 (USD Billion)
5.5. Enzymes
5.5.1. Enzymes Market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Other Applications Market, 2018 - 2030 (USD Billion)
5.1.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
5.2. Recombinant Proteins
5.2.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
5.3. Vaccines
5.3.1. Vaccines Market, 2018 - 2030 (USD Billion)
5.4. Hormones
5.4.1. Hormones Market, 2018 - 2030 (USD Billion)
5.5. Enzymes
5.5.1. Enzymes Market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Other Applications Market, 2018 - 2030 (USD Billion)
Chapter 6. End-Use Business Analysis
6.1. Mammalian Cell Fermentation Technology Market: End-Use Movement Analysis
6.2. Biopharmaceutical Companies
6.2.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Billion)
6.3. CMOs & CDMOs
6.3.1. CMOs & CDMOs, Market, 2018 - 2030 (USD Billion)
6.4. Academic And Research Institutes
6.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Billion)
6.2. Biopharmaceutical Companies
6.2.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Billion)
6.3. CMOs & CDMOs
6.3.1. CMOs & CDMOs, Market, 2018 - 2030 (USD Billion)
6.4. Academic And Research Institutes
6.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Billion)
Chapter 7. Regional Business Analysis
7.1. Mammalian Cell Fermentation Technology Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Mammalian Cell Fermentation Technology Market, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Danaher
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. F. Hoffmann-La Roche Ltd
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Sartorius AG
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AstraZeneca
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Bristol-Myers Squibb
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Amgen
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Gilead Sciences
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.11. Moderna, Inc
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Regeneron Pharmaceuticals
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Danaher
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. F. Hoffmann-La Roche Ltd
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Sartorius AG
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AstraZeneca
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Bristol-Myers Squibb
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Amgen
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Gilead Sciences
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.11. Moderna, Inc
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Regeneron Pharmaceuticals
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 3 Global mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 4 Global mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 5 Global mammalian cell fermentation technology market, by region, 2018 - 2030 (USD Billion)
Table 6 North America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 7 North America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 8 North America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 9 North America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 10 U.S. mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 12 U.S. mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 13 Canada mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 14 Canada mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 15 Canada mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Europe mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 17 Europe mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 18 Europe mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 19 Europe mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 20 UK mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 21 UK mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 22 UK mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Germany mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 24 Germany mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 25 Germany mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 26 France mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 27 France mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 28 France mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 29 Italy mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 30 Italy mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 31 Italy mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 32 Spain mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 33 Spain mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 34 Spain mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 35 Denmark mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 36 Denmark mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 37 Denmark mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 38 Sweden mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 39 Sweden mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 40 Sweden mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Norway mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 42 Norway mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 43 Norway mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 45 Asia Pacific mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 46 Asia Pacific mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 47 Asia Pacific mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 48 Japan mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 49 Japan mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 50 Japan mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 51 China mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 52 China mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 53 China mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 54 India mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 55 India mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 56 India mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 57 Australia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 58 Australia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 59 Australia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 60 Thailand mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 61 Thailand mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 62 Thailand mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 63 South Korea mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 64 South Korea mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 65 South Korea mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Latin America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 67 Latin America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 68 Latin America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 69 Latin America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 70 Brazil mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 71 Brazil mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 72 Brazil mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 73 Mexico mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 74 Mexico mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 75 Mexico mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 76 Argentina mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 77 Argentina mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 78 Argentina mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 79 Middle East & Africa mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 80 Middle East & Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD
Table 81 Middle East & Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 82 Middle East & Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 83 South Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 84 South Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 85 South Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 86 Saudi Arabia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 87 Saudi Arabia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 88 Saudi Arabia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 89 UAE mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 90 UAE mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 91 UAE mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 92 Kuwait mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 93 Kuwait mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 94 Kuwait mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 2 Global mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 3 Global mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 4 Global mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 5 Global mammalian cell fermentation technology market, by region, 2018 - 2030 (USD Billion)
Table 6 North America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 7 North America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 8 North America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 9 North America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 10 U.S. mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 12 U.S. mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 13 Canada mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 14 Canada mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 15 Canada mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Europe mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 17 Europe mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 18 Europe mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 19 Europe mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 20 UK mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 21 UK mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 22 UK mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Germany mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 24 Germany mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 25 Germany mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 26 France mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 27 France mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 28 France mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 29 Italy mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 30 Italy mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 31 Italy mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 32 Spain mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 33 Spain mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 34 Spain mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 35 Denmark mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 36 Denmark mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 37 Denmark mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 38 Sweden mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 39 Sweden mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 40 Sweden mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Norway mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 42 Norway mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 43 Norway mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 45 Asia Pacific mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 46 Asia Pacific mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 47 Asia Pacific mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 48 Japan mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 49 Japan mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 50 Japan mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 51 China mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 52 China mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 53 China mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 54 India mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 55 India mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 56 India mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 57 Australia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 58 Australia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 59 Australia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 60 Thailand mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 61 Thailand mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 62 Thailand mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 63 South Korea mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 64 South Korea mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 65 South Korea mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Latin America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 67 Latin America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 68 Latin America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 69 Latin America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 70 Brazil mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 71 Brazil mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 72 Brazil mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 73 Mexico mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 74 Mexico mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 75 Mexico mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 76 Argentina mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 77 Argentina mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 78 Argentina mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 79 Middle East & Africa mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 80 Middle East & Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD
Table 81 Middle East & Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 82 Middle East & Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 83 South Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 84 South Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 85 South Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 86 Saudi Arabia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 87 Saudi Arabia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 88 Saudi Arabia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 89 UAE mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 90 UAE mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 91 UAE mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 92 Kuwait mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 93 Kuwait mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 94 Kuwait mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Mammalian cell fermentation technology market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global mammalian cell fermentation technology market: Type movement analysis
Fig. 16 Global mammalian cell fermentation technology market, for Chinese Hamster Ovary (CHO) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 17 Global mammalian cell fermentation technology market, for Human Embryonic Kidney (HEK) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 18 Global mammalian cell fermentation technology market, for Baby Hamster Kidney (BHK) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 19 Global mammalian cell fermentation technology market, for murine myeloma cell fermentation, 2018 - 2030 (USD Billion)
Fig. 20 Global mammalian cell fermentation technology market, for other types, 2018 - 2030 (USD Billion)
Fig. 21 Global mammalian cell fermentation technology market: Application movement analysis
Fig. 22 Global mammalian cell fermentation technology market, for monoclonal antibodies, 2018 - 2030 (USD Billion)
Fig. 23 Global mammalian cell fermentation technology market, for recombinant protein, 2018 - 2030 (USD Billion)
Fig. 24 Global mammalian cell fermentation technology market, for vaccines, 2018 - 2030 (USD Billion)
Fig. 25 Global mammalian cell fermentation technology market, for hormones, 2018 - 2030 (USD Billion)
Fig. 26 Global mammalian cell fermentation technology market, for enzymes, 2018 - 2030 (USD Billion)
Fig. 27 Global mammalian cell fermentation technology market, for other applications, 2018 - 2030 (USD Billion)
Fig. 28 Global mammalian cell fermentation technology market: End-use movement analysis
Fig. 29 Global mammalian cell fermentation technology market, for biopharmaceutical companies, 2018 - 2030 (USD Billion)
Fig. 30 Global mammalian cell fermentation technology market, for CMOs & CDMOs, 2018 - 2030 (USD Billion)
Fig. 31 Global mammalian cell fermentation technology market, for academic and research institutes, 2018-030, (USD Billion)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 Global mammalian cell fermentation technology market: Region movement analysis
Fig. 35 North America mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 36 U.S. mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 37 Canada mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 38 Europe mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 39 Germany mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 40 UK mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 41 France mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 42 Italy mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 43 Spain mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 44 Denmark mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 45 Sweden mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 46 Norway mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 47 Asia Pacific mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 48 Japan mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 49 China mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 50 India mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 51 Australia mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 52 South Korea mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 53 Thailand mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 54 Latin America mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 55 Brazil mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 56 Mexico mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 57 Argentina mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 58 Middle East and Africa mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 59 South Africa mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 60 Saudi Arabia mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 61 UAE mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 62 Kuwait mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Mammalian cell fermentation technology market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global mammalian cell fermentation technology market: Type movement analysis
Fig. 16 Global mammalian cell fermentation technology market, for Chinese Hamster Ovary (CHO) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 17 Global mammalian cell fermentation technology market, for Human Embryonic Kidney (HEK) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 18 Global mammalian cell fermentation technology market, for Baby Hamster Kidney (BHK) cell fermentation, 2018 - 2030 (USD Billion)
Fig. 19 Global mammalian cell fermentation technology market, for murine myeloma cell fermentation, 2018 - 2030 (USD Billion)
Fig. 20 Global mammalian cell fermentation technology market, for other types, 2018 - 2030 (USD Billion)
Fig. 21 Global mammalian cell fermentation technology market: Application movement analysis
Fig. 22 Global mammalian cell fermentation technology market, for monoclonal antibodies, 2018 - 2030 (USD Billion)
Fig. 23 Global mammalian cell fermentation technology market, for recombinant protein, 2018 - 2030 (USD Billion)
Fig. 24 Global mammalian cell fermentation technology market, for vaccines, 2018 - 2030 (USD Billion)
Fig. 25 Global mammalian cell fermentation technology market, for hormones, 2018 - 2030 (USD Billion)
Fig. 26 Global mammalian cell fermentation technology market, for enzymes, 2018 - 2030 (USD Billion)
Fig. 27 Global mammalian cell fermentation technology market, for other applications, 2018 - 2030 (USD Billion)
Fig. 28 Global mammalian cell fermentation technology market: End-use movement analysis
Fig. 29 Global mammalian cell fermentation technology market, for biopharmaceutical companies, 2018 - 2030 (USD Billion)
Fig. 30 Global mammalian cell fermentation technology market, for CMOs & CDMOs, 2018 - 2030 (USD Billion)
Fig. 31 Global mammalian cell fermentation technology market, for academic and research institutes, 2018-030, (USD Billion)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 Global mammalian cell fermentation technology market: Region movement analysis
Fig. 35 North America mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 36 U.S. mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 37 Canada mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 38 Europe mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 39 Germany mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 40 UK mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 41 France mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 42 Italy mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 43 Spain mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 44 Denmark mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 45 Sweden mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 46 Norway mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 47 Asia Pacific mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 48 Japan mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 49 China mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 50 India mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 51 Australia mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 52 South Korea mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 53 Thailand mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 54 Latin America mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 55 Brazil mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 56 Mexico mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 57 Argentina mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 58 Middle East and Africa mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 59 South Africa mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 60 Saudi Arabia mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 61 UAE mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Fig. 62 Kuwait mammalian cell fermentation technology market, 2018 - 2030 (USD Billion)
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Danaher
- Lonza
- F. Hoffmann-La Roche Ltd
- Sartorius AG
- AstraZeneca
- Bristol-Myers Squibb
- Amgen
- Gilead Sciences
- Moderna, Inc
- Regeneron Pharmaceuticals
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 39.49 Billion |
| Forecasted Market Value ( USD | $ 76.24 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
